Recessive Dystrophic Bullous Epidermolysis With Squamous Cell Carcinoma: A Rare Case Report
Keywords:
Bullous Epidermolysis, Recessive Dystrophy, Squamous Cell CarcinomaAbstract
Epidermolysis bullosa (EB) is a genetic disorder in which the skin layer and other epithelia attached to the underlying connective tissue are disrupted with a tendency to form blisters and vesicles after mild trauma or friction. Other organs, like as the esophagus, can be damaged by some forms of EB, and subsequent problems might require several procedures. While there has been substantial progress in illness classification, specifically identifying the genes and proteins involved, there have been limited advancements in disease therapy. The care of an EB patient focuses on suppressing symptoms, protection of the skin, and minimizing complications. This case report presents the unique case of a 13-year-old girl diagnosed with recessive dystrophic epidermolysis bullosa complicated by squamous cell carcinoma. Multiple erosional efflorescences appear geographically defined boundaries covered with brownish yellow crusts, dystrophic scars, milia. Contractures of both fingers and toes (pseudosyndactyly) were present. The diagnosis was established through a comprehensive evaluation including history, physical examination, and relevant tests. The patient's parents did not have any of these problems and were not linked. There is no family history of the patient suffering from comparable problems. Therapy is therefore focused on the prevention of lesions and complications. The complexity of the therapeutic strategy depends on the severity of the patient's lesions. Optimal management of this disease can only be done through a multidisciplinary team of different disciplines. The management given is Sodium Fusidate cream every 12 hours applied to open erosions, open compresses NaCl 0.9% every 8 hours for 15-20 minutes, on crusts, levertrans on erosion areas. The prognosis for individuals with this condition remains uncertain, highlighting the challenges in addressing the complex nature of this disease.
Downloads
References
1. Amy S. Paller, Anthony J. Mancini. Hurwitz Clinical Pediatric Dermatology. In: Bullous disorders of childhood. 4th ed. Chicago, Illinois: Elsevier saunders; 2011. p. 303–13.
2. Woodley DT, Chen M. Epidermolysis Bullosa Acquisita. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick’s Dermatology. 9th ed. McGraw-Hill Education; 2019. p. 971–80.
3. Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, et al. Epidermolysis bullosa. Nat Rev Dis Prim 2020 61. 2020 Sep 24;6(1):1–27.
4. Tešanovi´c D, Perkovi´cperkovi´c T, Bukvi´c Z, Mokos B, Marinovi´cmarinovi´c B. Epidermolysis Bullosa Acquisita—Current and Emerging Treatments. J Clin Med 2023, Vol 12, Page 1139. 2023 Feb 1;12(3):1139.
5. Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ, Bieber K. Epidermolysis bullosa acquisita: The 2019 update. Front Med. 2019 Jan 1;6(JAN):419500.
6. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010 Dec 28;5(1):12.
7. Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006. J Am Acad Dermatol. 2009 Feb;60(2):203–11.
8. Dräger S, Ludwig RJ. Epidermolysis Bullosa Acquisita. Dis Oral Mucosa Study Guid Rev. 2023 Oct 29;247–53.
9. Uitto J, Richard G. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification. Clin Dermatol. 2005 Jan;23(1):33–40.
10. Tabolli S, Sampogna F, Di Pietro C, Paradisi A, Uras C, Zotti P, et al. Quality of life in patients with epidermolysis bullosa. British Journal of Dermatology. 2009 Oct;161(4):869–77.
11. Abu Sa’d J, Indelman M, Pfendner E, Falik-Zaccai TC, Mizrachi-Koren M, Shalev S, et al. Molecular Epidemiology of Hereditary Epidermolysis Bullosa in a Middle Eastern Population. Journal of Investigative Dermatology. 2006 Apr;126(4):777–81.
12. Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. British Journal of Dermatology. 2016 Jan 7;174(1):56–67.
13. Maldonado-Colin G, Hernández-Zepeda C, Durán-McKinster C, García-Romero M. Inherited epidermolysis bullosa: A multisystem disease of skin and mucosae fragility. Indian Journal of Paediatric Dermatology. 2017;18(4):267.
14. Pope E, Lara-Corrales I, Mellerio J, Martinez A, Schultz G, Burrell R, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol. 2012 Nov;67(5):904–17.
15. Vorobyev A, Ludwig RJ, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol. 2017 Feb 1;13(2):157–69.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Sissy Sissy, Mahfudz Shidiq, Clara Virginia Allun, Daniel Ahmad Romero (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.





